Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
4.410
-0.070 (-1.56%)
At close: Jul 19, 2024, 4:30 PM
4.480
+0.070 (1.59%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $47.45 million as of July 22, 2024. Its market cap has decreased by -14.51% in one year.
Market Cap
47.45M
Enterprise Value
9.28M
1-Year Change
-14.51%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $90.20M to $47.45M, a decrease of -47.40%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 47.40M | 1.94% |
| Dec 29, 2023 | 46.50M | -29.12% |
| Dec 30, 2022 | 65.60M | -26.54% |
| Dec 31, 2021 | 89.30M | -25.40% |
| Dec 31, 2020 | 119.70M | 32.71% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reneo Pharmaceuticals | 49.46M |
| DURECT | 49.35M |
| Modular Medical | 48.81M |
| Bionano Genomics | 48.13M |
| ARCA biopharma | 47.66M |
| NextCure | 47.27M |
| Vicarious Surgical | 46.79M |
| Apyx Medical | 46.77M |